Skip to content
For research use only. Not for human or veterinary use. Not a drug, food, or dietary supplement.
Cycle-length evidence

Pinealon cycle length: what human studies ran

Not approved — research use onlyCPreclinical research
Short answer: there is no established Pinealon cycle length or break. The human studies below ran for set periods under monitoring; none tested repeated courses.

Treatment and follow-up in human studies

  1. The locomotive-crew study administered Pinealon for two weeks 11.

What has not been tested

  • On-and-off schedules or breaks between courses.
  • Repeated courses and long-term exposure beyond the periods listed.
  • Pinealon combined with other compounds, unless a study above says so.

Frequently asked questions

Is there an established Pinealon cycle length?
No. Human studies administered Pinealon for the periods listed on this page. Those are study durations; none tested an on-and-off schedule or a break.
What is the longest human study of Pinealon?
The durations are listed on this page with their sources; compare them directly rather than relying on a summary.
Do study durations tell me how long to use something?
No. A study duration is how long investigators administered a compound to selected participants under monitoring. It is not a recommended course, and a break between courses has not been tested for any compound on this site that is not approved.

References

  1. Pinealon increases cell viability by suppression of free radical levels and activating proliferative processes Rejuvenation Res. 2011
  2. Pinealon protects the rat offspring from prenatal hyperhomocysteinemia Int J Clin Exp Med. 2012
  3. EDR Peptide: Possible Mechanism of Gene Expression and Protein Synthesis Regulation Involved in the Pathogenesis of Alzheimer's Disease Molecules. 2020
  4. Short peptides stimulate serotonin expression in cells of brain cortex Bull Exp Biol Med. 2014
  5. Penetration of short fluorescence-labeled peptides into the nucleus in HeLa cells and in vitro specific interaction of the peptides with deoxyribooligonucleotides and DNA Biochemistry (Mosc). 2011
  6. Drugs@FDA: FDA-Approved Drugs (search of approved applications) FDA Drugs@FDA / openFDA drug/drugsfda. 2026
  7. DailyMed label search (structured product labels) NLM DailyMed. 2026
  8. Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the FD&C Act, updated May 14, 2026 FDA. 2026
  9. World Anti-Doping Code International Standard: Prohibited List 2026 WADA. 2026
  10. Effect of short peptides on expression of signaling molecules in organotypic pineal cell culture Bull Exp Biol Med. 2011
  11. [Analysis of some parameters of biological age and adaptation possibilities of workers of locomotive brigades] Adv Gerontol. 2012
  12. [EFFECT OF SYNTHETIC PEPTIDES ON AGING OF PATIENTS WITH CHRONIC POLYMORBIDITY AND ORGANIC BRAIN SYNDROME OF THE CENTRAL NERVOUS SYSTEM IN REMISSION] Adv Gerontol. 2015
  13. [Comparative analysis of different methods of geroprotective] Adv Gerontol. 2016
  14. [The peptide correction of neurotic disorders among professional truck-drivers] Adv Gerontol. 2012